Skip to content

13F-HR filed by Altium Capital Management LLC

Altium Capital Management LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 118 holding rows worth $298,809,000.

Accession
0001420506-22-001092
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 118 entries on the cover page, a total value of $298,809,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $298,809,000 with VALUE read as thousands by filing date, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTAGONIST THERAPEUTICS74366E102COM5,000$11,840,000thousands by filing datecall
ESPERION THERAPEUTICS INC NEW COM29664W105Stock2,496,524$11,584,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM1,450,006$9,976,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM386,000$9,140,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM545,000$8,916,000thousands by filing date
PEPPERLIME HEALTH ACQUSTN COG70021129UNIT 99/99/9999735,000$7,232,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock126,000$6,852,000thousands by filing date
DEXCOM INC COM252131107Stock12,500$6,395,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock268,000$6,298,000thousands by filing date
QUIDEL CORP74838J101COM56,000$6,298,000thousands by filing date
ADMA BIOLOGICS INC000899104COM3,300,000$6,039,000thousands by filing date
GLOBUS MED INC CL A379577208Stock79,000$5,829,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW50,000$5,815,000thousands by filing date
NEVRO CORP64157F103COM77,000$5,569,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK206,000$5,560,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM1,750,000$5,443,000thousands by filing date
GLAUKOS CORP COM377322102Stock94,000$5,435,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS120,000$5,266,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM105,000$5,115,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S114ORDINARY SHARES500,000$5,040,000thousands by filing date
SHOCKWAVE MED INC82489T104COM23,000$4,769,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM645,000$4,754,000thousands by filing date
QIAGEN NVN72482123SHS NEW93,000$4,557,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock243,000$4,488,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock204,000$4,478,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK920,000$4,379,000thousands by filing date
XTANT MED HLDGS INC98420P308COM NEW6,246,291$4,247,000thousands by filing date
VERASTEM INC92337C104COM2,951,000$4,161,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock16,000$4,107,000thousands by filing date
LIVANOVA PLCG5509L101SHS50,000$4,092,000thousands by filing date
IVERIC BIO INC46583P102COM236,000$3,972,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN400,000$3,936,000thousands by filing date
ILLUMINA INC452327109COM11,000$3,843,000thousands by filing date
POLISHED COM INC28252C117*W EXP 06/02/2026,103,824$3,778,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM440,000$3,652,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM695,000$3,440,000thousands by filing date
IMMUNIC INC4525EP101COM300,000$3,390,000thousands by filing date
ADICET BIO INC007002108COM155,000$3,095,000thousands by filing date
MYRIAD GENETICS INC62855J104COM114,710$2,891,000thousands by filing date
KORU MEDICAL SYSTEMS INC759910102COMMON STOCK995,500$2,847,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock224,541$2,728,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM21,000$2,663,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN254,000$2,502,000thousands by filing date
MORPHIC HLDG INC61775R105COM60,000$2,409,000thousands by filing date
OUTSET MEDICAL INC690145107COM52,007$2,361,000thousands by filing date
HILLMAN SOLUTIONS CORP431636109COM196,000$2,328,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW66,000$2,248,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W102CMN225,000$2,228,000thousands by filing date
LANTHEUS HLDGS INC516544103COM40,000$2,212,000thousands by filing date
SILENCE THERAPEUTICS PLC82686Q101ADS109,000$2,071,000thousands by filing date
CARA THERAPEUTICS INC140755109COM165,000$2,005,000thousands by filing date
TG VENTURE ACQUISITION CORP87251T208UNIT 08/15/2028200,000$2,004,000thousands by filing date
GIGINTERNATIONAL1 INC37518W106CMN200,000$2,000,000thousands by filing date
MOBIX LABS INC COM CL AG2058L103Stock200,000$1,982,000thousands by filing date
LAKESHORE ACQUISITION I CORPG53521103ORDINARY SHARES200,000$1,982,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN200,000$1,966,000thousands by filing date
2SEVENTY BIO INC COMMON STOCK901384107Stock115,000$1,962,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW322,000$1,961,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM66,196$1,927,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM54,000$1,871,000thousands by filing date
PARDES BIOSCIENCES INC69945Q105COM253,000$1,827,000thousands by filing date
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK663,800$1,772,000thousands by filing date
RENOVACOR INC75989E106COM388,845$1,649,000thousands by filing date
PROCEPT BIOROBOTICS CORP COM74276L105Stock47,077$1,647,000thousands by filing date
DIGITAL HEALTH ACQUISITION C253893200UNIT 11/02/2026150,000$1,515,000thousands by filing date
AULT DISRUPTIVE TECHS CORP05150A104COM150,000$1,496,000thousands by filing date
SOMALOGIC INC83444K105COM180,000$1,444,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM299,800$1,400,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK22,500$1,377,000thousands by filing date
CURIS INC231269200COM540,800$1,287,000thousands by filing date
TAILWIND ACQUISITION CORP87403Q102COM CL A128,414$1,271,000thousands by filing date
PROFOUND MED CORP74319B502COM NEW124,945$1,125,000thousands by filing date
CUTERA INC232109108COM15,000$1,035,000thousands by filing date
FAT BRANDS INC30258N121*W EXP 07/16/202227,000$1,022,000thousands by filing date
MURPHY CANYON ACQUISITION CO626642201UNIT 01/25/2027100,000$1,010,000thousands by filing date
RELATIVITY ACQUISITION CORP75944B205UNIT 02/10/2027100,000$1,007,000thousands by filing date
INDUSTRIAL HUMAN CAPITAL INC45617P104CMN100,000$1,002,000thousands by filing date
WESTERN ACQSTN VENTURES CORP95758L206UNIT 09/01/2026100,000$1,000,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN100,000$987,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A100,000$982,000thousands by filing date
OPY ACQUISITION CORP I671005106COM100,000$980,000thousands by filing date
ARYA SCIENCES ACQU CORP IVG31659108COM100,000$980,000thousands by filing date
SADOT GROUP INC627333107COM1,796,961$948,000thousands by filing date
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK122,000$924,000thousands by filing date
COLISEUM ACQUISITION CORPG2263T123COM85,000$825,000thousands by filing date
VIQ SOLUTIONS INC91825V400COM NEW489,417$798,000thousands by filing date
VERRICA PHARMACEUTICALS INC92511W108COM97,887$794,000thousands by filing date
DOUBLEDOWN INTERACTIVE CO LT25862B109ADS60,876$722,000thousands by filing date
GSR II METEORA ACQUISITN COR36263W204UNIT 02/24/202750,000$506,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H108COM50,000$484,000thousands by filing date
TC BIOPHARM HOLDINGS PLC87807D111*W EXP 02/10/202941,176$461,000thousands by filing date
LIGHTNING EMOTORS INC 11.5000EXP05/18/202553228T119WARR652,173$268,000thousands by filing date
Renovacor Inc75989E114Warrant731,561$249,000thousands by filing date
HARBOR CUSTOM DEVELOPMENT IN41150T124*W EXP 10/07/202650,000$240,000thousands by filing date
SURGEPAYS INC86882L113*W EXP 10/22/202250,000$223,000thousands by filing date
CEA INDUSTRIES INC86887P119*W EXP 02/11/202250,000$171,000thousands by filing date
IMMATICS N.VN44445117*W EXP 07/01/20297,467$171,000thousands by filing date
HARBOR CUSTOM DEVELOPMENT IN41150T116*W EXP 05/09/202600,000$171,000thousands by filing date
PEPPERLIME HEALTH ACQUSTN COG70021111*W EXP 10/01/202367,500$152,000thousands by filing date
DIRECT DIGITAL HOLDINGS INC25461T113*W EXP 02/15/202180,000$131,000thousands by filing date
Cingulate Inc W Exp 12/10/20217248W113Warrant270,000$108,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S106RIGHT 12/26/2025500,000$105,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS10,000$99,000thousands by filing date
NEXGEL INC65344E115*W EXP 12/27/202225,000$88,000thousands by filing date
CALITHERA BIOSCIENCES INC COM NEW13089P101Stock202,276$82,000thousands by filing date
NLS PHARMACEUTICS LTDH57830111*W EXP 02/02/202200,000$76,000thousands by filing date
LAKESHORE ACQUISITION I CORPG53521111*W EXP 07/15/202150,000$53,000thousands by filing date
CHAVANT CAPITAL ACQUISITN COG2058L111*W EXP 99/99/999150,000$30,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W110*W EXP 10/23/20275,000$27,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/202133,333$25,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS84,666$24,000thousands by filing date
SURROZEN INC86889P117*W EXP 08/01/20382,233$21,000thousands by filing date
OPY ACQUISITION CORP I671005114*W EXP 09/22/20250,000$20,000thousands by filing date
WTS AULT DISRUPTIVE TECHNOLOGI05150a112WT112,500$19,000thousands by filing date
INDUSTRIAL HUMAN CAPITAL INC45617P112WTS100,000$18,000thousands by filing date
GIGINTERNATIONAL1 INC37518W114*W EXP 04/19/20250,000$18,000thousands by filing date
COLISEUM ACQUISITION CORPG2263T107*W EXP 08/22/20228,333$10,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H116*W EXP 99/99/99916,666$5,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-001092this filing2022-05-16acceptance time not in the bulk data set